Invitation to media and analyst briefing for BioGaia Q4 and full year 2022 report
BioGaia's (NASDAQ: BIOG) financial report for the fourth quarter and full year of 2022 will be published at approximately 8:00 AM CET on February 3, 2023.
The company will issue a press release with the complete financial report attached, including tables. Following publication of the press release, the financial report will be available on BioGaia's website (https://www.biogaia.com/investors/financial-reports/).
CEO Isabelle Ducellier and CFO Alexander Kotsinas will comment on the report and take questions at a live audiocast at 9:30 AM CET.
To join the audiocast with teleconference and ask a question, please click here: https://financialhearings.com/event/46019
Subscribe to BioGaia press releases here (https://www.biogaia.com/press/subscribe-to-press-releases/)
LinkedIn here (https://www.linkedin.com/company/biogaia-ab/)
BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in more than 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaia.com (http://www.biogaia.com)